www.fdanews.com/articles/163906-pharma-blog-watch
Pharma Blog Watch
April 17, 2014
One and Done (In the Pipeline Blog)
A Forbes piece claiming that, between 1950 and 2011, 56 percent of drug companies receiving FDA approval did so only once does not bode well for Pharmacyclics, says Derek Lowe — especially if its CEO contributes to Scientology.
A Forbes piece claiming that, between 1950 and 2011, 56 percent of drug companies receiving FDA approval did so only once does not bode well for Pharmacyclics, says Derek Lowe — especially if its CEO contributes to Scientology.